ANIKA THERAPEUTICS INC (ANIK)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ANIK
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ANIK | Director | 68 | [] | ["Audit"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MDT | Retired Chief Financial Officer | 68 | ["corporate finance expert","retired MedTech executive","former Vice President, Chief Financial Officer of Stryker Corporation","15 years at Dentsply International in leadership positions including CFO","experience serving on boards of directors of healthcare companies","Senior Advisor for Astor Place Holdings","more than 40 years of business, financial, and executive management experience","expertise in executive leadership, strategic portfolio management, and financial operations"] | ["M","Growth","Operations","Audit","Quality"] | 2026 |
| AVNT | Senior Advisor | 68 | ["Former Vice President, Chief Financial Officer of Stryker Corporation", "Senior Vice President and Chief Financial Officer of Dentsply International", "Extensive experience in the Medtech industry", "Diverse operating experiences in international markets"] | ["M"] | 2026 |
| SYK | Vice President and Chief Financial Officer | [] | [] | 2014 |
Biography sourced from the proxy statement filing.
Vice President, Chief Financial Officer of Stryker Corporation (Nasdaq: SYK), a global leader in medical technologies, from April 2013 to January 2016 Various offices, including Senior Vice President and Chief Financial Officer, at Dentsply International from 1998 to 2013 Various roles of increasing responsibility, and leadership roles, including Vice President of Finance, Treasurer and Corporate Controller, of Donnelly Corporation from 1980 to 1998 Director of Young Innovations from 2017 to present Director of Solenis LLC from February 2025 to present Recent Public Company Board Service Telix Pharmaceuticals Limited (Nasdaq: TLX), a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies, effective May 2026 Medtronic, Inc (NYSE: MDT), a global healthcare technology company that develops, manufactures and markets a variety of device-based therapies and services, from 2025 to present Avient Corp (NYSE: AVNT), a premier formulator of specialized and sustainable materials solutions, from 2015 to present Masimo Corporation (Nasdaq: MASI), a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies, from September 2024 to August 2025 Education B.A. in Business Administration from Hope College Relevant Skills Medical Devices/Pharmaceutical Experience, R&D/Innovation Expertise, Commercialization/Marketing Expertise, M&A/Business Development Expertise, Financial Oversight/Accounting Expertise, Regulatory Expertise, and International/Global Business Experience acquired as a veteran MedTech executive and corporate finance expert, with over 25 years in the medical device and healthcare industries, including his significant executive leadership experience, global brand management, marketing, sales and product development, operations Public Company Governance/Corporate Responsibility Expertise obtained through his experience serving on boards of directors